Glenmark Pharmaceuticals Limited (GLENMARK.NS) NSE
2,184.60
-16.59995(-0.75%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 601.54B |
| Enterprise Value | 595.72B |
| P/E Ratio | 45.27 |
| PEG Ratio | 1.51 |
| Price/Sales Ratio | 3.63 |
| Price/Book Ratio | 5.87 |
| Enterprise/Revenue | 3.6 |
| Enterprise/EBITDA | 20.69 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.08 |
| Operating Margin | 0.2 |
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | 0.14 |
Income Statement
| Revenue | 169.83B |
| Revenue/Share | 601.74 |
| Gross Profit | 80.84B |
| EBITDA | 45.72B |
| Net Income | 13.62B |
| Diluted EPS | 48.24 |
Balance Sheet
| Total Cash | 11.76B |
| Total Cash/Share | 41.68 |
| Total Debt | 5.94B |
| Total Debt/Equity | 0.06 |
| Current Ratio | 1.77 |
| Book Value Per Share | 372.46 |
Price History
| 52-Week Change | 45.88 |
| 52-Week High | 2,474 |
| 52-Week Low | 1,473.3 |
| Moving Average 50 Days | 2,270 |
| Moving Average 200 Days | 2,057.74 |
Statistics
| Average Volume | 740,759 |
| Shares Outstanding | 282.2M |
| % Held by Institutions | 0.05 |
Dividend And Splits
| Trailing Annual Dividend Rate | 5 |
| Trailing Annual Dividend Yield | 0.23 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | September 10, 2007 |
